![The Believe Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept in Adult Beta-Thalassemia Patients Who Require Regular Red Blood Cell Transfusions The Believe Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept in Adult Beta-Thalassemia Patients Who Require Regular Red Blood Cell Transfusions](https://congressreport.eu/storage/app/media/ASH_2018/ASH_2018_Maria_Domenica_Cappellini_EA.jpg)
The Believe Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept in Adult Beta-Thalassemia Patients Who Require Regular Red Blood Cell Transfusions
![ASH on Twitter: ASH on Twitter:](https://pbs.twimg.com/ext_tw_video_thumb/1335369823203758080/pu/img/1mVBApm3dtV0wqMC.jpg:large)
ASH on Twitter: "We are pleased to recognize Maria Domenica Cappellini, MD, of the University of Milan in Italy with the 2020 Henry M. Stratton Medal. Congratulate her with #ASHKudos and view
![Guidelines for the Management of Non-Transfusion Dependent Thalassaemia (NTDT) (2nd Edition – 2017) – TIF Guidelines for the Management of Non-Transfusion Dependent Thalassaemia (NTDT) (2nd Edition – 2017) – TIF](https://thalassaemia.org.cy/wp-content/uploads/2017/10/NTDTs-2nd-edition-cover-233x300.png)
Guidelines for the Management of Non-Transfusion Dependent Thalassaemia (NTDT) (2nd Edition – 2017) – TIF
![YoungEHA on Twitter: YoungEHA on Twitter:](https://pbs.twimg.com/media/E35-r2JXoAMdP4-.jpg)